# Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11

> **NCT00000259** · NA · COMPLETED · sponsor: **University of Chicago** · enrollment: 12 (actual)

## Conditions studied

- Opioid-Related Disorders
- Substance-Related Disorders

## Interventions

- **DRUG:** 15 % Nitrous oxide
- **DRUG:** 0.3 % Sevoflurane
- **DRUG:** 30% Nitrous oxide
- **DRUG:** 0.6% Sevoflurane
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00000259
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-08
- **Primary completion:** 1997-11
- **Final completion:** 1997-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000259, "Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00000259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*